Skip to content

Impact of pediatric epilepsy surgery on healthcare resource use.

Aug 2026 · Epilepsy Research · Vol 227, pp. 107901 · 0 citations · 29 references
Medicine

TL;DR

Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries.

Abstract

Objective

To quantify healthcare resource use before and after epilepsy surgery among pediatric patients with drug-resistant epilepsy, stratifying by type of surgery, type of insurance, race, and ethnicity.

Methods

Retrospective descriptive study of the Pediatric Health Information System (PHIS) database in the period 2004-2024. Our main outcome was healthcare resource use.

Results

1288 patients (median (p25-p75) age at first epilepsy surgery: 11.0 (6.8-15.3) years, 43% females) had a total of 1538 epilepsy surgeries. Although the median (p25-p75) cost of epilepsy surgery was high [$88,512 ($51,283-$145,159)], after epilepsy surgery (versus before epilepsy surgery) there was a decrease in number of hospital admissions per person-year [0.6 (0.2-1.3) versus 1.4 (0.8-2.4), p < 0.0001], days of hospital stay per person-year [1.5 (0.3-5.0) versus 4.4 (2.2-9.1), p < 0.0001], and total healthcare resource use per person-year [$15,571 ($4,465-$44,089) versus $28,100 ($14,723-$58,455), p < 0.0001]. Decreases in healthcare resource use were more pronounced among patients who required only one epilepsy surgery than in patients who needed subsequent epilepsy surgeries. Decreases in healthcare resource use were similar for all types of surgeries except when the first surgery was laser interstitial thermal therapy (LITT) or ablation or radiosurgery (mainly because many of these patients required subsequent surgeries), for all types of insurances, for all races, and for all ethnicities.

Conclusion

Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries. Results were similar for all types of insurance, for all races, and for all ethnicities.

View source

Similar papers

Sep 2026

Severe COVID-19 outcomes in patients with epilepsy: evidence from a nationwide, population-based study in Poland.

The findings suggest that PWE - particularly those with substantial comorbidity burden - represent a clinically vulnerable population in the context of COVID-19 and may require heightened clinical attention and preventive strategies.

Aleksandra Pawlicka, Marcin Kruk, B. Koń et al. · 0 citations
Open access Sep 2026

Utilization of Anti-Seizure Medication (ASMS) and Seizure Control in Pediatric Epilepsy: A Retrospective Cross-Sectional Study in Oman

Dose adjustments, particularly dose increases, were associated with a higher frequency of adverse effects, and careful dose optimization may therefore be important to balance tolerability and seizure management.

Y. Nomier, Yaqeen Al-Aamri, Rawan Al-Toqi et al. · 0 citations
Open access Jul 2026

Does age influence diagnostic outcomes in an adult cohort referred to a first-seizure clinic?

The findings underscore the importance of careful, age-sensitive diagnostic evaluation, and highlight the need for further research to elucidate age-related diagnostic patterns and refine inclusion criteria and workup strategies in first-seizure clinics.

Anne Line Lund Birkmose, Corinna Lackmann, L. Pinborg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.